VESICARE 5 MG Oral Tablet
- RxCUI
- 539817
- RxNorm name
- VESICARE 5 MG Oral Tablet
- Display name
- VESICARE 5 MG Oral Tablet
- Full name
- VESICARE 5 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:10
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VESIcare | SOLIFENACIN SUCCINATE | Astellas Pharma US, Inc. | 9acee910-cdb2-4052-b8b3-c26aff1c8716 | 2022-10-31 | Warnings, Adverse reactions | 539817 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 9acee910-cdb2-4052-b8b3-c26aff1c8716 | VESICARE 5 MG Oral Tablet | PSN | 30 | These highlights do not include all the information needed to use VESICARE safely and effectively. See full prescribing information for VESICARE. VESICARE ® (solifenacin succinate) tablets, for oral use Initial U.S. Approval: 2004 | 20221031 |
| 9acee910-cdb2-4052-b8b3-c26aff1c8716 | VESIcare 5 MG Oral Tablet | SY | 30 | These highlights do not include all the information needed to use VESICARE safely and effectively. See full prescribing information for VESICARE. VESICARE ® (solifenacin succinate) tablets, for oral use Initial U.S. Approval: 2004 | 20221031 |
| 9acee910-cdb2-4052-b8b3-c26aff1c8716 | solifenacin succinate 5 MG Oral Tablet [Vesicare] | SBD | 30 | These highlights do not include all the information needed to use VESICARE safely and effectively. See full prescribing information for VESICARE. VESICARE ® (solifenacin succinate) tablets, for oral use Initial U.S. Approval: 2004 | 20221031 |
| 100678f1-313a-4e99-ae77-319c610a830f | VESICARE 5 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use VESIcare ® safely and effectively. See full prescribing information for VESIcare. VESIcare (solifenacin succinate) tablets Initial U.S. Approval: 2004 | 20171228 |
| 100678f1-313a-4e99-ae77-319c610a830f | VESIcare 5 MG Oral Tablet | SY | 2 | These highlights do not include all the information needed to use VESIcare ® safely and effectively. See full prescribing information for VESIcare. VESIcare (solifenacin succinate) tablets Initial U.S. Approval: 2004 | 20171228 |
| 100678f1-313a-4e99-ae77-319c610a830f | solifenacin succinate 5 MG Oral Tablet [Vesicare] | SBD | 2 | These highlights do not include all the information needed to use VESIcare ® safely and effectively. See full prescribing information for VESIcare. VESIcare (solifenacin succinate) tablets Initial U.S. Approval: 2004 | 20171228 |
| e433dc68-6b2a-4c48-beae-4ec946f1ff1e | VESICARE 5 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use VESIcare ® safely and effectively. See full prescribing information for VESIcare. VESIcare (solifenacin succinate) tablets Initial U.S. Approval: 2004 | 20120306 |
| e433dc68-6b2a-4c48-beae-4ec946f1ff1e | VESIcare 5 MG Oral Tablet | SY | 2 | These highlights do not include all the information needed to use VESIcare ® safely and effectively. See full prescribing information for VESIcare. VESIcare (solifenacin succinate) tablets Initial U.S. Approval: 2004 | 20120306 |
| e433dc68-6b2a-4c48-beae-4ec946f1ff1e | solifenacin succinate 5 MG Oral Tablet [Vesicare] | SBD | 2 | These highlights do not include all the information needed to use VESIcare ® safely and effectively. See full prescribing information for VESIcare. VESIcare (solifenacin succinate) tablets Initial U.S. Approval: 2004 | 20120306 |